Jones Financial Companies’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.97K Buy
612
+36
+6% +$388 ﹤0.01% 3774
2025
Q4
$6.15K Buy
576
+410
+247% +$4.91K ﹤0.01% 3417
2025
Q3
$2.28K Hold
166
﹤0.01% 3650
2025
Q2
$2.25K Sell
166
-84
-34% -$1.1K ﹤0.01% 3431
2025
Q1
$3.46K Buy
250
+166
+198% +$2.49K ﹤0.01% 3077
2024
Q4
$1.48K Hold
84
﹤0.01% 3073
2024
Q3
$1.61K Hold
84
﹤0.01% 2717
2024
Q2
$1.83K Buy
+84
New +$2.24K ﹤0.01% 2176

Other funds holding MED

Jones Financial Companies's MED Position: Q1 2026 in Review

Jones Financial Companies increased its Medifast (MED) stake by 6.3% in Q1 2026, buying an estimated $388 and bringing the position to 612 shares worth $5.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3774.

Jones Financial Companies first reported a position in MED in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.15K in Q4 2025. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

  • Jones Financial Companies held 612 shares of Medifast worth $5.97K as of Q1 2026.
  • Jones Financial Companies bought 36 Medifast shares in Q1 2026, an estimated $388.
  • Medifast made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3774 holding.
  • Jones Financial Companies first reported a position in Medifast in Q2 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Medifast position peaked at $6.15K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.